5 completed, 1 recruiting. 3 Phase 3, 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Recruiting 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Vertanical GmbH: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy VER-01, Placebo - Lumbosacral Radiculopathy | Phase 3 | Recruiting | Vertanical GmbH | 810 | 2026-09-22 | 2026-10-21 |
| Dose-Response Characterization of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain VER-01, Placebo - Chronic Non-specific Low Back Pain | Phase 2 | Completed | Vertanical GmbH | 652 | 2024-06-28 | 2025-08-11 |
| Comparison of VER-01 to Opioids in Patients With Chronic Non-specific Low Back Pain VER-01, Opioid therapy - Chronic Non-specific Low Back Pain | Phase 3 | Completed | Vertanical GmbH | 384 | 2023-06-08 | 2024-11-25 |
| Food Effect Study of VER-01 in Healthy Volunteers VER-01 - Healthy | Phase 1 | Completed | Vertanical GmbH | 18 | 2022-08-10 | 2022-11-28 |
| Single and Multiple Dose Study of VER-01 in Healthy Volunteers VER-01 - Healthy | Phase 1 | Completed | Vertanical GmbH | 42 | 2021-11-25 | 2022-07-14 |
| Efficacy and Safety of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain VER-01, Placebo - Chronic Non-specific Low Back Pain | Phase 3 | Completed | Vertanical GmbH | 820 | 2021-07-07 | 2024-04-08 |
Marijuana Abuse (2) · Back Pain (1) · Chronic Pain (1) · Low Back Pain (1) · Neuralgia (1)
Analgesics, Opioid (1) · Opiate Substitution Treatment (1)
Austria (2) · Germany (2) · United Kingdom (1) · United States (1)
Michael Wolzt, Professor (2) · Joachim Nadstawek, Prof. (1) · Martin Johnson, Dr. (1) · Matthias Karst, Prof.Dr.med. (1)
2023 (1)